Simon Plyte is the Chief Scientific Officer at Biomunex Pharmaceuticals, bringing over 20 years of leadership experience in the biotechnology industry. His expertise is in immuno-oncology and the discovery of innovative drugs, particularly bispecific antibodies. He holds a PhD in biochemistry and biophysics from the University of Portsmouth.
He is pioneering the development of MAIT engagers, a novel class of bispecific antibodies intended to provide a safer and more effective cancer therapy.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.